SCHEMBL1633137

SCHEMBL1633137

CCOC(=O)CC[C@H](CSCc1ccc(OC)cc1)NC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PKM P14618 2/20 0.44
ACE P12821 2/20 0.43
ALOX15 P16050 1/20 0.42
ATM Q13315 1/20 0.42
KMT2A Q03164 3/20 0.41
GLA P06280 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
MAPT P10636 4/20 0.41
LTA4H P09960 1/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
CCR6 P51684 1/20 0.39
HKDC1 Q2TB90 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632889 0.91 GAA (0.47) GAAALDH1A1SMN1; SMN2PKMACE
SCHEMBL1277752 0.85 PPARG (0.56) GAAALDH1A1SMN1; SMN2PKMACE
SCHEMBL1277755 0.85 PPARG (0.56) GAAALDH1A1SMN1; SMN2PKMACE
SCHEMBL1277634 0.83 GAA (0.46) GAAALDH1A1SMN1; SMN2PKMACE
Hydrochloric Acid SCHEMBL1277633 0.82 GAA (0.46) GAAALDH1A1SMN1; SMN2PKMACE
Hydrochloric Acid SCHEMBL1277637 0.82 GAA (0.46) GAAALDH1A1SMN1; SMN2PKMACE
SCHEMBL1633922 0.80 GAA (0.50) GAAALDH1A1SMN1; SMN2PKMACE
SCHEMBL7997853 0.79 ALDH1A1 (0.59) GAAALDH1A1SMN1; SMN2PKMALOX15
SCHEMBL1633974 0.77 PPARG (0.46) GAAALDH1A1SMN1; SMN2PKMACE
SCHEMBL1632933 0.77 ACE (0.46) GAAALDH1A1SMN1; SMN2PKMACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309586-B2 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient LG LIFE SCIENCES LTD. (KR) 2012-11-13 US disclosed
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG CHEM, LTD. (KR) 2012-04-12 US disclosed
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG LIFE SCIENCES LTD. (KR) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT GCKR, GCK, GALK1 GAA 51/4885ALDH1A1 1309/4885SMN1; SMN2 3804/4885
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT GCK, GCKR, HK1 GAA 50/4885ALDH1A1 1242/4885SMN1; SMN2 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.